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Multivariate analysis demonstrated that P-year MACE rate was related to post-procedural 
minimal lumen diameter < 2.46 mm (p = 0.013), previous myocardial infarction (p = 
0.0206), stent diameter of 3 mm (p = 0.0325) and hypertension (p = 0.0422). 
Conclusion : In comparison with DS-, these results show that DS+ has a similar rate of 
cardiac events at long-term follow-up and don’t reduce the incidence late restenosis. 
1078-14 Stents Covered by Autoiogoue Venous Grafts in Human 
Coronary Arteries: Five-year Follow-up 
mToutouzas, Christodoulos Stefanadis. Eleftherios Tsiamis, Sophia Vaina, 
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Background: The mid-term results after the implantation of autologous venous-graft 
covered stents (AVGCS) in human coronary arteries were favorable. The aim of our 
study was to present the long-term results of this technique. Morover, a comparison was 
performed with the long-term results of uncovered stents. Methods: A venous graft was 
removed from an upper limb. Conventional stents then were covered either both inter- 
nally and externally, or only externally by autologous venous grafts. Fifty-eight AVGCS 
were implanted in 56 patients, including 16 patients with acute coronary syndromes 
(ACS). Additionally, in the control group we enrolled 114 patients, in whom 136 uncov- 
ered stents were implanted including 36 patients with ACS. The demographic character- 
istics of the two groups were similar. Results: The procedure was successful in all 
patients. Acute thrombosis was observed in 3 patients of the control group. One patient 
with an AVGCS pressnted with subacute thrombosis. The restsnosis rate was 13.3% in 
covered stents vs 20.6% (p=NS). All patients were examined clinically or interviewed by 
telephone communication at a mean of 62.4 * 14.5 months in AVGCS group and 65.3 f 
12.7 months in the control group. The minimal lumen diameter had a trend to be greater 
in the AVGCS group at follow-up (2.22 f 0.9 vs 2.10 * 0.9 mm, p=O.O7). The target ves- 
sel revascularization rate was 14% in the AVGCS group vs 17.1% in the control group 
(p=NS). The event-free sumival rate at 4 years was 62% in the AVGCS YS 79% in the 
control group (p=NS). The event-free survival rate in ACS was 92% in AVGCS versus 
75% in the control group, respectively (P = 0.06). Stents covered by thicker venous grafts 
were associated with improved clinical outcome. Conclusions: Stents covered by autol- 
ogous venous grafts may be safely prepared without complications. The long-term 
results after AVGCS implantation showed that covered stems by venous grafts are not 
associated with late complications, which are related to the technique. 
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Background: Gold coatings enhance the radiopacity 01 steel stems, facilitating stem 
deployment into the target lesion. However, it remains uncertain whether gold coatings 
are a risk factor for restenosis after coronary stenting. The aim of this study was to deter- 
mine whether gold-coatings increase the risk of in-stent restenosis in patients with coro- 
nary artery disease. 
Methods: Two hundred and ten patients with 210 lesions (diameter stenosis > 50%. 
lesion length 2.5 mm) were randomly assigned to receive either an uncoated NIR stem 
group (Group I, n=105) or a gold-coated NIR stent group (Group II, n=105). The primary 
end point was angiographic restenosis at 6 months follow-up. and the secondary end 
point was major adverse cardiac events during 9 months. 
Results: The baseline characteristics were similar between the two groups. Procedural 
success rate was 99.0% in group I and 100% in group II. In-hospital events did not occur 
in any patients. Angiographic follow-up were obtained in 169 patients (61.3% of those eli- 
gible), and the rates of angiographic restenosis were 27.1% in group I, and 44.0% in 
group II (~~0.05). Acute gain was not different between the two groups. However, late 
loss and loss index were significantly higher in group II than in group I (PcO.05). There 
was a trend of a higher incidence of major adverse cardiac events in group I than in 
group II (16.2% vs 26.7%, respectively, p=O.O6). 
Conclusion: Gold coatings may increase the risk of restenosis after coronary stenting. 
1078-16 The Morphological and Histological Findings of 
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Background: We have repotted the low restenosis rate of Igaki-Tamai biodegradable self- 
expanding Stent within 6 months in the human coronary arteries. We analyzed the mor- 
phology and histology of in-stent restenosis 01 the stent and initial outcomes of target 
lesion revascularization (TLR). Method: Sixty-three lesions in 50 patients underwent 
poly-L-lactic acid (PLLA) stem implantation for coronary artery stsnosis. Eleven lesions 
(17.5%) in 10 patients revealed restenosis (%diameter stenosis > 50% at follow-up) and 
6 lesions in 5 patients received TLA within 6 months. We assessed an angiographic clas- 
sification of in-stent rsstenosis according to the geographic distribution of intimal hyper- 
plasia. Removed tissues of restenosis by dirsctlonal coronary atherectomy (DCA) were 
histologically examined by light-microscope and electron-microscope. Results: The refer- 
ence vessel diameter of 11 restenotic lesions before stent implantation was 2.97t0.49 
mm and the lesion length was 12.2~4.5 mm by quantitative coronary angiography. The 
morphology of 11 in-stem restenosis were 2 focal body, 4 focal margin, 2 diffuse intras- 
tent, 2 diffuse proliferative and 1 total occlusion. One focal marginal, 1 diffuse intrastent, 
1 diiuse proliferative and 1 total occluded in-stem restsnosis received repeat balloon 
angioplasty. One focal marginal and 1 diffuse intrastent in-stent restenosis received 
repeat angioplasty by DCA. The in-stem restenosis were easily dilated by balloon angio- 
plasty and easily excised by DCA. The stent struts were also easily excised by DCA. No 
major cardiac events such as death, myocardial infarction or bypass surgery associated 
with repeat angioplasty developed within the follow-up period. The histological findings 
revealed that there were proliferation of fibroblastic cells with myxoid stromal component 
partially surrounding the stem materials and no evidence of thrombogenesis nor foreign 
body response. Conclusions: Repeat angioplasty for in-stent restenosis of Igaki-Tamai 
stent performed easily and safely. The morphology of in-stem restenosis was similar to 
that of metallic stents and histological findings suggest biocompatibility of PLLA stent. 
1078-17 Causes of Death in Patients With in-Sent Reetenoeie 
mFarb, Breno S. Pessanha, Allen P. Burke. Renu Virmani, Armed f%ces institute 
of Pathology, Washington, Dist. of Columbia. 
Background: Stenting is standard treatment for coronary revascularization. and stems 
generally perform favorably with respect to patient survival. However, there have been no 
data reported on the causes of death with autopsy confirmation in patients with initially 
successful coronary stenting. 
Methods: From an ongoing registry study of human coronary artery stents submitted for 
pathologic analysis, patients with coronary stents deployed >3 months antemortem were 
identified. Clinical history and autopsy findings were reviewed. Stems and coronary arter- 
ies underwent detailed histologic evaluation. 
Results: The study group consisted of 67 patients (42 men, 25 women; age 59f13 
years) with coronary stenting performed a mean of 10 months antemortem. Coronary 
death (CD) accounted for 50167 (75%) cases and non-CD was responsible for the 
remaining 17 (25%). In-stent restenosis (ISR) was present in 50 cases: 43/50 (66%) with 
CD and 7117 (41%) with non-CD (p<O.OOl). Of the 50 ISR patients, death was associated 
with: (1) ISR alone, without severe atherosclerosis in other major coronary arteries, in 17 
cases (34%): (2) ISR with severe atherosclerosis in >l additional non-stented coronaty 
artery in 23 cases (46%); and (3) complications following repeat revascularizatfon (cathe- 
ter-based or CABG) in 10 cases (20%), all with severs atherosclerosis in 21 additional 
non-stented coronary artery. Of patients with ISR, 35% were symptomatic prior to death 
or attempted revascularization. Acute thrombosis of non-stented coronary arteries was 
present in 5 patients, and late stent thrombosis was seen in an additional 5 cases (3 of 
which with associated ISR). Notably, 32 of the 50 cases of CD after stenting were sudden 
and unexpected (64%). 
Conclusions: In patients dying after successful coronary stenting, >75% have ISR, of 
which a majority have multi-vessel coronary atherosclerosis involving non-stented arter- 
ies. Sudden coronary death is common. The data support long-term follow-up of patients 
with coronary stsnts to identity in-stem restenosis and progressive atherosclerosis to pre- 
vent late cardiac death. 
1078-18 Local Delivery of Evans Blue Significantly Prevents in- 
Stent Restenoeie in Patients With Acute Myocardial 
infarction 
sFullmori. Hiroshi Mario, Kuniko Terasawa, Takashi Shiga, Masaru Hatano, 
Masaaki Osegawa, Yasumi Uchida, Toshihiro Morita, Narita Red Cross Hospital, Narita, 
Japan, University of Tokyo, Tokyo, Japan. 
Background Restenosis remains to be solved in coronary intervention. Especially, in- 
Stent restenosis occurs more frequently in patients with acute myocardial infarction (AMI) 
than in those with angina pectoris. We evaluated the effect of local delivery of Evans blue 
dye on prevention of restenosis in patients with AMI. 
Methods Eighty-one patients with AMI. who were treated with primary stent, were ran- 
domized to two groups. In 41 patients, including 33 males and 6 females (59.0+6.6 years 
old, mean f SD), we administered 1 ml of 2% Evans blue dye (20mg) by local delivety 
technique, using porous balloon catheter 3 weeks after the onset (Evans blue group). 
Residual 40 patients (34 males and 6 females, 61.4*9.5 years old), consisted a control 
group without administration of Evans blue dye. Rsstenosis was defined as diameter 
stenosis more than 50% on coronary angiography (CAG) at 7-month follow-up. 
Results Stents used were Multi-Link and GFX stsnts in both groups, and there were no 
differences in lesion distribution, stem diameter, length, and ratio of both stents between 
two groups. Just after stem implantation, there were no differences between two groups 
in reference luminal diameter (3.26+0.39mm vs. 3.19t 0.33mm, Evans blue group vs. 
control group), minimal luminal diameter (3.20+0.31mm vs. 3.07a0.39mm). and diameter 
stenosis (2.3t6.1% vs. 3.2*10.6%). All patients completed follow up CAG (mean, 7 
months). At follow up CAG, reference luminal diameter was not different between Evans 
blue and control group (3.14*0.43mm vs. 3.15+0.32mm, ns). Minimal luminal diameter 
was significantly larger in Evans blue group (2.64&79mm vs. 1.91&.76mm. p<O.o005). 
Diameter stenosis was significantly lower in Evans blue group (17.2*19.1% vs. 
39.5&3.6%, pcO.0005). Restenosis rate was also significantly lower in Evans blue group 
(5% vs. 25%, p<O.O5). 
Conclusion Local delivery of Evans blue dye significantly prevented in-stsnt intimal pro- 
liferation and rsstenosis in patients with AMI. 
